BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 31874284)

  • 61. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis.
    Watanabe A; Miyajima M; Mishina T; Nakazawa J; Harada R; Kawaharada N; Higami T
    Gen Thorac Cardiovasc Surg; 2013 May; 61(5):254-61. PubMed ID: 23188513
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
    Kolek V; Vašáková M; Šterclová M; Cwiertka K; Vrána D; Kudláček A; Skřičková J; Pešek M; Petera J
    Klin Onkol; 2017; 30(4):303-306. PubMed ID: 28832178
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.
    Tzouvelekis A; Gomatou G; Bouros E; Trigidou R; Tzilas V; Bouros D
    Chest; 2019 Aug; 156(2):383-391. PubMed ID: 31125557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. IPF, comorbidities and management implications.
    Vancheri C; Cottin V; Kreuter M; Hilberg O
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():17-23. PubMed ID: 26237439
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice.
    Karampitsakos T; Sampsonas F; Herazo-Maya JD; Tzouvelekis A
    Curr Opin Pulm Med; 2023 Sep; 29(5):416-426. PubMed ID: 37395506
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Research Progress on the Pathogenesis of Lung Cancer Associated with 
Idiopathic Pulmonary Fibrosis].
    Lu Q; Han S; Liu X
    Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):811-818. PubMed ID: 36419395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Idiopathic pulmonary fibrosis-an epidemiological and pathological review.
    Borchers AT; Chang C; Keen CL; Gershwin ME
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):117-34. PubMed ID: 20838937
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanical forces: The missing link between idiopathic pulmonary fibrosis and lung cancer.
    Wang C; Yang J
    Eur J Cell Biol; 2022; 101(3):151234. PubMed ID: 35569385
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?
    Lettieri S; Oggionni T; Lancia A; Bortolotto C; Stella GM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
    Nalysnyk L; Cid-Ruzafa J; Rotella P; Esser D
    Eur Respir Rev; 2012 Dec; 21(126):355-61. PubMed ID: 23204124
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer.
    Stella GM; Gentile A; Balderacchi A; Meloni F; Milan M; Benvenuti S
    J Transl Med; 2016 Sep; 14(1):256. PubMed ID: 27590450
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of the effects of COVID-19 on patients with pulmonary fibrosis and lung cancer: a bioinformatics analysis and literature review.
    Li Y; Niu L
    Sci Rep; 2022 Sep; 12(1):16040. PubMed ID: 36163484
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges.
    Abu Qubo A; Numan J; Snijder J; Padilla M; Austin JHM; Capaccione KM; Pernia M; Bustamante J; O'Connor T; Salvatore MM
    Breathe (Sheff); 2022 Dec; 18(4):220147. PubMed ID: 36865932
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidemiology and management of common pulmonary diseases in older persons.
    Akgün KM; Crothers K; Pisani M
    J Gerontol A Biol Sci Med Sci; 2012 Mar; 67(3):276-91. PubMed ID: 22337938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.
    Tzouvelekis A; Karampitsakos T; Gomatou G; Bouros E; Tzilas V; Manali E; Tomos I; Trachalaki A; Kolilekas L; Korbila I; Tomos P; Chrysikos S; Gaga M; Daniil Z; Bardaka F; Papanikolaou IC; Euthymiou C; Papakosta D; Steiropoulos P; Ntolios P; Tringidou R; Papiris S; Antoniou K; Bouros D
    Pulm Pharmacol Ther; 2020 Feb; 60():101880. PubMed ID: 31874284
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Idiopathic pulmonary fibrosis will increase the risk of lung cancer.
    Li J; Yang M; Li P; Su Z; Gao P; Zhang J
    Chin Med J (Engl); 2014; 127(17):3142-9. PubMed ID: 25189961
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update.
    Antoniou KM; Tomassetti S; Tsitoura E; Vancheri C
    Curr Opin Pulm Med; 2015 Nov; 21(6):626-33. PubMed ID: 26390339
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lung cancer in patients with idiopathic pulmonary fibrosis.
    Karampitsakos T; Tzilas V; Tringidou R; Steiropoulos P; Aidinis V; Papiris SA; Bouros D; Tzouvelekis A
    Pulm Pharmacol Ther; 2017 Aug; 45():1-10. PubMed ID: 28377145
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lung cancer in lung transplant recipients: experience of a tertiary hospital and literature review.
    Raviv Y; Shitrit D; Amital A; Fox B; Rosengarten D; Fruchter O; Bakal I; Kramer MR
    Lung Cancer; 2011 Nov; 74(2):280-3. PubMed ID: 21529983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.